Two Wyss Center Startups Selected for the 2025 Venture Leaders Medtech Team
Taking Swiss neurotechnology to the global stage in Boston
We are proud to announce that two Wyss Center startups — Clee Medical SA and dEEGtal Insights SA — have been selected to join the 2025 Venture Leaders Medtech program. The two ventures are among ten outstanding Swiss medtech startups chosen for a prestigious international roadshow that will take place in Boston, USA, from September 28 to October 3, 2025.
The Venture Leaders Medtech program aims to fast-track the international expansion of high-potential Swiss medtech startups. Following a highly competitive selection process with over 70 applications, a jury of seasoned investors and healthcare industry experts selected ten startups that demonstrated strong innovation, commercial potential, and readiness for international growth.
Both Clee Medical SA and dEEGtal Insights SA are developing breakthrough neurotechnologies to improve clinical care and transform the lives of people living with mental health and neurological disorders.
By participating in the Venture Leaders Medtech roadshow, these startups will gain access to one of the world’s most dynamic life sciences ecosystems. Over the course of one week, the teams will have the opportunity to pitch to top US investors, connect with industry leaders and potential partners, and explore strategic entry points into the US healthcare market.
“We are delighted to see Clee Medical SA and dEEGtal Insights SA reach this exciting milestone,” said Erwin Böttinger, CEO of the Wyss Center for Bio and Neuroengineering. “This recognition is a testament to their exceptional vision, innovation, and dedication to transforming patient outcomes. We look forward to seeing them grow and succeed internationally.”
Discover the ten 2025 Venture Leaders of the Medtech Program
- Clee Medical SA: transforming brain surgery with real-time vision and control, and making brain surgery faster, safer and improving patient outcomes.
- dEEGtal Insights SA: revolutionizing epilepsy diagnosis with an AI-powered software that provides rapid results, and supports neurologists in making earlier, more reliable decisions.
- Augury Medical GmbH: Improving patient care with novel heartbeat visualization.
- Babylat AG: On-site human milk fortifiers for preterm neonates in NICUs.
- DigeHealth AG: 24/7 non-invasive solution for bowel obstruction prevention.
- Hemetron AG: Better treatments through accurate mobile health tests.
- Inteeth SA: Aesthetic and Patient-Friendly Orthodontics.
- NX-Spine: Platform technology for bone reinforcement.
- OrthoSens SA: Making implants talk to improve orthopaedic recovery.
- Scanvio Medical AG: AI-guided ultrasound for faster endometriosis diagnosis.
Save the Date – Online Pitch Session
Before heading to Boston, the ten selected startups will be introduced during an online pitch session on August 19, 2025. This public event will offer a unique opportunity to discover cutting-edge medtech solutions and hear directly from the entrepreneurs driving them forward.